日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The Regulatory Interplay of the Colorectal Cancer Biomarkers MACC1 and IER2 and Its Impact on Metastatic Cancer Survival

结直肠癌生物标志物MACC1和IER2的调控相互作用及其对转移性癌症生存的影响

Alberto Vilchez, Miguel Enrique; Kortüm, Benedikt; Schöpe, Paul; Kyjacova, Lenka; Zincke, Fabian; Osterland, Marc; Smith, Janice; Walther, Wolfgang; Rau, Beate; Sleeman, Jonathan Paul; Stein, Ulrike

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease

早期阿尔茨海默病甘特鲁单抗临床试验中的淀粉样蛋白相关影像异常(ARIA)

Salloway, Stephen; Wojtowicz, Jakub; Voyle, Nicola; Lane, Christopher A; Klein, Gregory; Lyons, Marco; Rossomanno, Simona; Mazzo, Francesca; Bullain, Szofia; Barkhof, Frederik; Bittner, Tobias; Schneider, Andres; Grundman, Michael; Aldea, Roxana; Boada, Mercè; Smith, Janice; Doody, Rachelle

Japanese participant data from three gantenerumab trials in early Alzheimer's disease

来自三项针对早期阿尔茨海默病患者的gantenerumab试验的日本参与者数据

Asada, Takashi; Thanasopoulou, Angeliki; Delmar, Paul; Wojtowicz, Jakub; Smith, Janice; Yoshiyama, Yasumasa; Yokoi, Katsunori; Watanabe, Chigusa; Isozaki, Mitsuhiro; Ozaki, Ryoto; Ishida, Takaaki; Tatsuda, Hironori; Tamaoka, Akira

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease

了解靶向β-淀粉样蛋白疗法对阿尔茨海默病生物标志物和临床终点的影响

Petersen, Ronald C; Graf, Ana; Atkins, Alexandra S; Brys, Miroslaw; Murphy, Jennifer; Miller, David S; Reyderman, Larisa; Siemers, Eric; Smith, Janice; Carrillo, Maria C; Weber, Christopher J

Induction of circulating ABCB1 transcripts under platinum-based chemotherapy indicates poor prognosis and a bone micrometastatic phenotype in ovarian cancer patients

铂类化疗诱导循环ABCB1转录本表达预示卵巢癌患者预后不良和骨微转移表型。

Schwarz, Franziska Maria; Kuhlmann, Jan Dominik; Kämpfer, Jorrin; Klimova, Anna; Klotz, Daniel Martin; Freitag, Lisa; Herrmann, Pia; Zinnow, Viktoria; Smith, Janice; Scheller, Theresia; Walther, Wolfgang; Wimberger, Pauline; Stein, Ulrike

Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease

促进临床试验的多样性:从ALUMNI AD研究的规划中汲取经验,该研究针对的是美国历史上代表性不足的早期症状性阿尔茨海默病患者群体

Wise-Brown, Alexandria; Brangman, Sharon A; Henderson, J Neil; Willis-Parker, Monica; Monroe, Stephanie; Mintzer, Jacobo E; Grundman, Michael; Smith, Janice; Doody, Rachelle S; Lin, Helen; Assman, Beverly; Rippon, Gregory A; Gonzales, Rozanno; Assunção, Sheila Seleri

Homozygous, Intragenic Tandem Duplication of SFTPB Causes Neonatal Respiratory Failure

SFTPB基因纯合子内串联重复导致新生儿呼吸衰竭

Wambach, Jennifer A; Wegner, Daniel J; Kitzmiller, Joseph; White, Frances V; Heins, Hillary B; Yang, Ping; Paul, Alexander J; Granadillo, Jorge L; Eghtesady, Pirooz; Kuklinski, Cadence; Turner, Tiffany; Fairman, Korre; Stone, Kristyne; Wilson, Theodore; Breman, Amy; Smith, Janice; Schroeder, Molly C; Neidich, Julie A; Whitsett, Jeffrey A; Cole, F Sessions

Long-Term Safety of Gantenerumab in Participants with Alzheimer's Disease: A Phase III, Double-Blind, and Open-Label Extension Study (Marguerite RoAD)

Gantenerumab 在阿尔茨海默病患者中的长期安全性:一项 III 期、双盲、开放标签扩展研究(Marguerite RoAD)

Neve, Anuja; Das, Bibha; Wojtowicz, Jakub; Huang, Zhiyue; Bullain, Szofia; Watkin, Michelle; Lott, Dominik; Bittner, Tobias; Delmar, Paul; Klein, Gregory; Hofmann, Carsten; Kerchner, Geoffrey A; Smith, Janice; Baudler, Monika; Fontoura, Paulo; Doody, Rachelle S

Two Phase 3 Trials of Gantenerumab in Early Alzheimer's Disease

Gantenerumab治疗早期阿尔茨海默病的两项3期临床试验

Bateman, Randall J; Smith, Janice; Donohue, Michael C; Delmar, Paul; Abbas, Rachid; Salloway, Stephen; Wojtowicz, Jakub; Blennow, Kaj; Bittner, Tobias; Black, Sandra E; Klein, Gregory; Boada, Mercè; Grimmer, Timo; Tamaoka, Akira; Perry, Richard J; Turner, R Scott; Watson, David; Woodward, Michael; Thanasopoulou, Angeliki; Lane, Christopher; Baudler, Monika; Fox, Nick C; Cummings, Jeffrey L; Fontoura, Paulo; Doody, Rachelle S

Predictors of placebo response in three large clinical trials of the V1a receptor antagonist balovaptan in autism spectrum disorder

在三项大型临床试验中,V1a受体拮抗剂巴洛伐坦治疗自闭症谱系障碍的安慰剂反应预测因素

Tobe, Russell; Zhu, Yajing; Gleissl, Teresa; Rossomanno, Simona; Veenstra-VanderWeele, Jeremy; Smith, Janice; Hollander, Eric